Identification Module
The Identification Module contains basic identifying information about the clinical trial, including the NCT ID, brief title, official title, acronym, organization study ID information, and organization details. This module provides essential identifiers for the trial.
Identification Module path is as follows:
Study -> Protocol Section -> Identification Module
Identification Module
Ignite Creation Date:
2025-12-24 @ 3:59 PM
Ignite Modification Date:
2025-12-24 @ 3:59 PM
NCT ID:
NCT00010192
Brief Title:
Rituximab Plus Interleukin-2 in Treating Patients With Hematologic Cancer
Official Title:
A Phase I Trial Of Rituximab And Interleukin-2
Study:
NCT00010192
Protocol Section:
NCT00010192